Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Edward Dempsey

Concepts (333)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neprilysin
6
2017
47
2.460
Why?
Muscle, Smooth, Vascular
22
2017
420
2.360
Why?
Pulmonary Artery
26
2020
1031
1.850
Why?
Protein Kinase C
15
2007
274
1.830
Why?
Hypoxia
18
2021
937
1.380
Why?
rho GTP-Binding Proteins
2
2020
62
1.260
Why?
Pulmonary Circulation
7
2009
407
1.000
Why?
Isoenzymes
9
2007
285
0.750
Why?
Hypertension, Pulmonary
12
2021
1749
0.730
Why?
Lung
11
2021
3672
0.700
Why?
Evans Blue
1
2018
6
0.640
Why?
Capillary Permeability
1
2018
138
0.610
Why?
Cell Division
25
2009
759
0.580
Why?
Protein Kinase C-epsilon
3
2005
26
0.570
Why?
Myocytes, Smooth Muscle
2
2019
239
0.560
Why?
Muscle Proteins
1
2017
209
0.530
Why?
Blood Vessels
3
2016
181
0.510
Why?
Endothelium, Vascular
2
2020
845
0.450
Why?
Aging
4
2020
1631
0.440
Why?
Animals
44
2021
32102
0.440
Why?
Mice, Knockout
6
2017
2604
0.430
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
24
0.430
Why?
Animals, Newborn
10
2007
780
0.390
Why?
Airway Remodeling
1
2010
60
0.360
Why?
Pulmonary Disease, Chronic Obstructive
3
2017
1098
0.320
Why?
Cattle
16
2002
935
0.300
Why?
Fibroblasts
7
2019
839
0.290
Why?
Mice
14
2018
15052
0.290
Why?
Endothelin-1
2
2017
167
0.250
Why?
Protein Kinases
1
2007
306
0.250
Why?
Signal Transduction
7
2020
4541
0.250
Why?
Lung Neoplasms
11
2012
2207
0.240
Why?
Enzyme Activation
5
2017
793
0.230
Why?
rho-Associated Kinases
2
2019
81
0.220
Why?
Cells, Cultured
12
2017
3914
0.210
Why?
Vascular Remodeling
2
2021
151
0.210
Why?
Lung Diseases
2
2007
710
0.210
Why?
Mice, Inbred C57BL
5
2017
4773
0.210
Why?
Insulin-Like Growth Factor I
3
1997
281
0.210
Why?
Potassium Channels, Voltage-Gated
1
2002
48
0.210
Why?
Vascular Endothelial Growth Factor Receptor-2
3
2012
88
0.210
Why?
Cell Movement
3
2017
867
0.200
Why?
Vasoconstriction
1
2002
185
0.190
Why?
Growth Substances
4
1997
136
0.190
Why?
Tetradecanoylphorbol Acetate
5
1997
153
0.190
Why?
Butyrates
1
2021
53
0.190
Why?
Proto-Oncogene Proteins c-myc
2
2020
114
0.190
Why?
Metabolic Diseases
1
2021
99
0.180
Why?
Phenotype
5
2017
2829
0.180
Why?
Mitogens
2
1997
58
0.180
Why?
Forkhead Box Protein O3
1
2020
13
0.180
Why?
Receptors, G-Protein-Coupled
1
2021
192
0.170
Why?
Platelet-Derived Growth Factor
3
1997
82
0.170
Why?
Vasa Vasorum
1
2020
33
0.170
Why?
JNK Mitogen-Activated Protein Kinases
1
2020
146
0.170
Why?
rhoA GTP-Binding Protein
1
2019
75
0.160
Why?
Cellular Microenvironment
1
2019
78
0.160
Why?
Genotype
2
2017
1786
0.160
Why?
Metabolome
1
2021
287
0.160
Why?
Pulmonary Alveoli
2
2012
376
0.160
Why?
Thymidine
5
1996
58
0.150
Why?
ets-Domain Protein Elk-1
1
2017
13
0.150
Why?
Smooth Muscle Myosins
1
2017
7
0.150
Why?
Kruppel-Like Transcription Factors
1
2017
61
0.150
Why?
Actins
3
2017
383
0.140
Why?
Microfilament Proteins
1
2017
126
0.140
Why?
Vascular Diseases
1
2019
230
0.140
Why?
Calcium-Binding Proteins
1
2017
203
0.140
Why?
Substance P
1
2016
44
0.130
Why?
Chronic Disease
6
2009
1598
0.130
Why?
Doxycycline
1
2016
56
0.130
Why?
Duodenum
1
2016
63
0.130
Why?
Pneumonia
1
2021
576
0.130
Why?
Neovascularization, Pathologic
5
2020
283
0.130
Why?
Sleep Apnea Syndromes
2
2013
74
0.130
Why?
Uterus
3
2006
193
0.120
Why?
Humans
30
2021
115587
0.120
Why?
Carcinogens
2
2012
105
0.120
Why?
Cell Communication
1
1996
282
0.120
Why?
In Vitro Techniques
5
2007
1044
0.120
Why?
Myocardium
1
2019
926
0.120
Why?
Sputum
3
2005
290
0.120
Why?
Endothelial Cells
3
2021
695
0.110
Why?
Estradiol
2
1997
452
0.110
Why?
Enzyme Inhibitors
4
2002
757
0.110
Why?
Cell Proliferation
2
2017
2194
0.110
Why?
Gene Expression Regulation, Developmental
1
1997
794
0.110
Why?
Piperidines
2
2012
163
0.100
Why?
Blotting, Western
3
2012
1153
0.100
Why?
Quinazolines
2
2012
241
0.100
Why?
Gene Expression Regulation
3
2016
2353
0.100
Why?
Mice, Transgenic
1
2016
1970
0.090
Why?
Gene Expression Regulation, Enzymologic
2
2005
274
0.090
Why?
Bronchoscopy
5
2009
245
0.090
Why?
DNA Primers
2
2009
514
0.090
Why?
Somatomedins
1
1990
29
0.090
Why?
Cardiovascular Diseases
1
2021
1724
0.090
Why?
Carcinoma in Situ
3
2005
44
0.090
Why?
Arteries
2
2006
250
0.090
Why?
Precancerous Conditions
3
2004
156
0.090
Why?
Maleimides
3
2000
24
0.090
Why?
Biomarkers
1
2020
3466
0.080
Why?
Isotretinoin
1
2009
22
0.080
Why?
Blood Pressure
3
2021
1537
0.080
Why?
Tocopherols
1
2009
22
0.080
Why?
ErbB Receptors
1
2012
557
0.080
Why?
Cell Hypoxia
3
1999
220
0.080
Why?
Biomarkers, Tumor
3
2012
1048
0.080
Why?
Female
17
2012
59913
0.080
Why?
Carcinoma, Squamous Cell
2
2005
577
0.070
Why?
Male
10
2018
55949
0.070
Why?
Indoles
3
2000
309
0.070
Why?
Galectin 1
1
2006
2
0.070
Why?
Bronchi
2
2000
250
0.070
Why?
Heart Failure
1
2019
1963
0.070
Why?
Genes, ras
2
1997
91
0.070
Why?
Hyperoxia
1
2007
97
0.070
Why?
Videotape Recording
1
2006
30
0.070
Why?
Thiazolidinediones
1
2006
143
0.060
Why?
Rats, Sprague-Dawley
3
2021
2262
0.060
Why?
Disease Models, Animal
2
2013
3580
0.060
Why?
Smoking
4
2009
1457
0.060
Why?
Hypertrophy, Right Ventricular
2
2021
142
0.060
Why?
DNA
4
1997
1356
0.060
Why?
Rats
4
2021
5034
0.060
Why?
Nitric Oxide Synthase Type II
1
2005
160
0.060
Why?
Blood
2
1995
97
0.060
Why?
Nitric Oxide Synthase Type III
1
2005
185
0.060
Why?
Calcium
2
2002
1103
0.060
Why?
Endothelins
2
1996
61
0.060
Why?
Drug Synergism
3
1996
317
0.060
Why?
Hemodynamics
1
2009
968
0.060
Why?
Drug Delivery Systems
1
2007
301
0.060
Why?
Guinea Pigs
3
2006
151
0.060
Why?
Bronchoalveolar Lavage Fluid
2
1997
608
0.060
Why?
Case-Control Studies
1
2010
3022
0.060
Why?
Fetus
2
1997
702
0.050
Why?
Shaw Potassium Channels
1
2002
4
0.050
Why?
Intracellular Signaling Peptides and Proteins
1
2005
388
0.050
Why?
Potassium Chloride
1
2002
35
0.050
Why?
Stem Cells
1
2007
546
0.050
Why?
Potassium Channel Blockers
1
2002
29
0.050
Why?
Angiotensin II
1
2002
91
0.050
Why?
Potassium Channels
1
2002
121
0.050
Why?
Nitric Oxide Synthase
1
2002
213
0.050
Why?
Antineoplastic Agents
2
2010
1893
0.050
Why?
Tunica Media
2
1998
35
0.050
Why?
Urethane
2
2012
41
0.050
Why?
Protein Kinase C beta
2
2000
24
0.050
Why?
Macrophages
2
2021
1284
0.050
Why?
Gene Deletion
1
2002
355
0.050
Why?
Systole
1
2021
169
0.050
Why?
Patient Education as Topic
1
2006
686
0.050
Why?
Aged
6
2010
19251
0.050
Why?
Fluorescence
1
2001
154
0.050
Why?
Tight Junctions
1
2021
68
0.050
Why?
Microvessels
1
2021
68
0.050
Why?
Acetylation
1
2021
212
0.050
Why?
Genetic Predisposition to Disease
1
2009
2125
0.050
Why?
Receptors, Purinergic P2Y
1
2020
7
0.040
Why?
Nitric Oxide
1
2005
832
0.040
Why?
Cytokines
2
2021
1853
0.040
Why?
Ligands
1
2021
569
0.040
Why?
Neoplasms
1
2013
2118
0.040
Why?
GTPase-Activating Proteins
1
2019
71
0.040
Why?
Guanine Nucleotide Exchange Factors
1
2019
56
0.040
Why?
Trans-Activators
1
2001
370
0.040
Why?
Light
1
2001
337
0.040
Why?
Up-Regulation
1
2021
820
0.040
Why?
Oxygen
1
2002
837
0.040
Why?
Immune System
1
2019
173
0.040
Why?
Leukocytes
1
2019
281
0.040
Why?
Phosphatidylinositol 3-Kinases
1
2020
332
0.040
Why?
Aorta
2
2001
353
0.040
Why?
Proto-Oncogene Proteins c-akt
1
2020
400
0.040
Why?
Middle Aged
5
2010
26999
0.040
Why?
Adenosine Triphosphate
1
2020
431
0.040
Why?
Culture Media, Serum-Free
1
1997
42
0.040
Why?
Disease Susceptibility
1
2019
316
0.040
Why?
Proto-Oncogene Proteins c-sis
1
1997
35
0.040
Why?
Ischemia
1
2000
363
0.040
Why?
Protein Kinase C-alpha
1
1997
41
0.040
Why?
TOR Serine-Threonine Kinases
1
2020
362
0.040
Why?
Organ Specificity
1
1997
273
0.040
Why?
Nuclear Proteins
1
2001
594
0.040
Why?
Sensitivity and Specificity
2
2001
1718
0.040
Why?
Pregnancy, Animal
1
1997
52
0.040
Why?
Muscle Development
1
1997
93
0.030
Why?
Bronchial Neoplasms
1
1996
14
0.030
Why?
Reactive Oxygen Species
1
2019
549
0.030
Why?
Microcirculation
2
2007
138
0.030
Why?
Heart Ventricles
1
2021
712
0.030
Why?
Species Specificity
1
1997
552
0.030
Why?
Rabbits
1
1997
752
0.030
Why?
Blood Physiological Phenomena
1
1996
14
0.030
Why?
Point Mutation
1
1997
217
0.030
Why?
Tritium
1
1996
69
0.030
Why?
Receptors, Platelet-Derived Growth Factor
1
1996
13
0.030
Why?
Dose-Response Relationship, Drug
2
2010
1870
0.030
Why?
Neoplasms, Second Primary
1
1997
91
0.030
Why?
Exercise
1
2006
1609
0.030
Why?
Rats, Inbred Strains
1
1996
376
0.030
Why?
Myocytes, Cardiac
1
2019
457
0.030
Why?
DNA Mutational Analysis
1
1996
372
0.030
Why?
Young Adult
1
2010
10470
0.030
Why?
Protein Precursors
1
1996
119
0.030
Why?
Quality of Life
1
2006
2385
0.030
Why?
Clinical Trials as Topic
1
2019
941
0.030
Why?
Catalysis
1
1995
299
0.030
Why?
Subcellular Fractions
1
1994
78
0.030
Why?
Models, Biological
1
2021
1646
0.030
Why?
Flow Cytometry
2
1996
1083
0.030
Why?
Adenosine Diphosphate
1
1994
81
0.030
Why?
Stress, Mechanical
1
1996
440
0.030
Why?
Recombinant Proteins
1
1997
1243
0.030
Why?
Poly I-C
1
1994
52
0.030
Why?
Blood Proteins
1
1996
238
0.030
Why?
Risk Factors
5
2009
8697
0.030
Why?
Endothelin Receptor Antagonists
1
1993
58
0.030
Why?
Hyperplasia
2
2006
166
0.030
Why?
Neoplasm Proteins
1
1996
385
0.030
Why?
Receptors, Estrogen
1
1996
372
0.030
Why?
Complement Factor B
1
1994
100
0.030
Why?
Extracellular Matrix
2
2006
439
0.030
Why?
Serotonin
1
1994
296
0.030
Why?
Methylcholanthrene
1
2012
18
0.030
Why?
Butylated Hydroxytoluene
1
2012
32
0.030
Why?
Adolescent
1
2010
17889
0.030
Why?
Pregnancy
3
2006
5548
0.030
Why?
Immunoenzyme Techniques
1
2012
193
0.020
Why?
Time Factors
2
2007
6165
0.020
Why?
Peptides, Cyclic
1
1993
262
0.020
Why?
Infant, Newborn
2
2007
5077
0.020
Why?
Blood Platelets
1
1994
350
0.020
Why?
Apoptosis
1
2000
2377
0.020
Why?
Phorbol 12,13-Dibutyrate
1
1991
9
0.020
Why?
Cell Count
2
2006
305
0.020
Why?
Aerobiosis
1
1991
20
0.020
Why?
Anaerobiosis
1
1991
49
0.020
Why?
Dimethyl Sulfoxide
1
1991
43
0.020
Why?
Epithelial-Mesenchymal Transition
1
2012
167
0.020
Why?
Tumor Cells, Cultured
3
1996
850
0.020
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
225
0.020
Why?
Protein Binding
1
1996
1917
0.020
Why?
Chemoprevention
1
2010
88
0.020
Why?
Biopsy
2
2005
1056
0.020
Why?
DNA Replication
1
1991
203
0.020
Why?
Antioxidants
1
2012
533
0.020
Why?
RNA, Messenger
1
1996
2574
0.020
Why?
Down-Regulation
1
1990
601
0.020
Why?
Molecular Targeted Therapy
1
2010
348
0.020
Why?
Leukocyte Common Antigens
1
2007
76
0.020
Why?
Kinetics
1
1991
1569
0.020
Why?
Rats, Inbred WKY
1
2006
32
0.020
Why?
Elastin
1
2006
78
0.020
Why?
Proto-Oncogene Proteins c-kit
1
2006
63
0.020
Why?
Codon
2
1997
86
0.020
Why?
Aged, 80 and over
2
2009
6417
0.020
Why?
Serum
1
2006
57
0.020
Why?
PPAR gamma
1
2006
185
0.020
Why?
Vascular Resistance
1
2006
338
0.020
Why?
Chi-Square Distribution
1
2006
499
0.020
Why?
Protein Kinase Inhibitors
1
2010
790
0.020
Why?
Collagen
1
2006
415
0.010
Why?
Sheep
1
2006
764
0.010
Why?
Antibodies, Monoclonal
1
2010
1265
0.010
Why?
Adenocarcinoma
1
2010
799
0.010
Why?
Neoplasm Recurrence, Local
1
2009
863
0.010
Why?
Polymerase Chain Reaction
2
1997
1000
0.010
Why?
Teaching
1
2006
224
0.010
Why?
Neoplasm Invasiveness
1
2005
445
0.010
Why?
Epithelial Cells
2
2001
961
0.010
Why?
Confidence Intervals
1
2004
309
0.010
Why?
Vital Capacity
1
2004
277
0.010
Why?
Activities of Daily Living
1
2006
352
0.010
Why?
Gestational Age
1
2006
757
0.010
Why?
Bronchopulmonary Dysplasia
1
2007
330
0.010
Why?
Base Sequence
1
2006
2114
0.010
Why?
Forced Expiratory Volume
1
2004
516
0.010
Why?
Patient Compliance
1
2006
524
0.010
Why?
CREB-Binding Protein
1
2001
27
0.010
Why?
Metaplasia
1
2001
54
0.010
Why?
Adaptation, Psychological
1
2006
551
0.010
Why?
Single-Blind Method
1
2001
255
0.010
Why?
Fluorescent Antibody Technique
1
2001
398
0.010
Why?
Chromosomes, Human, Pair 3
1
2000
49
0.010
Why?
Loss of Heterozygosity
1
2000
41
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
57
0.010
Why?
Ki-67 Antigen
1
2000
104
0.010
Why?
Carcinoma
1
2001
200
0.010
Why?
Fibrosis
1
2002
457
0.010
Why?
Airway Obstruction
1
2001
168
0.010
Why?
Prevalence
1
2005
2264
0.010
Why?
Risk
1
2001
819
0.010
Why?
Carcinoma, Non-Small-Cell Lung
2
1997
963
0.010
Why?
Cell Death
1
2000
326
0.010
Why?
Mitotic Index
1
1997
26
0.010
Why?
Bromodeoxyuridine
1
1997
73
0.010
Why?
Cytoskeletal Proteins
1
1997
145
0.010
Why?
Tunica Intima
1
1997
78
0.010
Why?
Myosins
1
1997
126
0.010
Why?
Mammals
1
1999
251
0.010
Why?
Chromosome Banding
1
1996
21
0.010
Why?
Ploidies
1
1996
17
0.010
Why?
Comorbidity
1
2001
1473
0.010
Why?
Ovariectomy
1
1997
117
0.010
Why?
Karyotyping
1
1996
102
0.010
Why?
Ligases
1
1996
32
0.010
Why?
Tumor Suppressor Protein p53
1
2000
449
0.010
Why?
Bronchoalveolar Lavage
1
1996
89
0.010
Why?
Heparin
1
1997
227
0.010
Why?
Immunohistochemistry
1
2000
1642
0.010
Why?
Immunophenotyping
1
1996
277
0.010
Why?
Transcription, Genetic
1
2001
1310
0.010
Why?
Regional Blood Flow
1
1997
414
0.010
Why?
HeLa Cells
1
1996
567
0.010
Why?
Mass Screening
1
2001
1024
0.010
Why?
Adult
2
2009
30718
0.010
Why?
Surveys and Questionnaires
1
2006
4665
0.010
Why?
Calcimycin
1
1994
46
0.010
Why?
Epidermal Growth Factor
1
1994
161
0.010
Why?
Prognosis
1
2001
3339
0.010
Why?
Interferon-beta
1
1994
79
0.010
Why?
Mice, Inbred C3H
1
1994
244
0.010
Why?
Neoplasm Staging
1
1997
1178
0.010
Why?
Cell Survival
1
1996
1024
0.010
Why?
Macrophage Activation
1
1994
165
0.010
Why?
Analysis of Variance
1
1993
1227
0.010
Why?
Interferon-gamma
1
1994
726
0.010
Why?
Mutation
1
2000
3364
0.010
Why?
Peptides
1
1994
864
0.010
Why?
Tumor Necrosis Factor-alpha
1
1994
1137
0.000
Why?
Retrospective Studies
1
2005
12608
0.000
Why?
Dempsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)